Search Results - Jonathan Kay
- Showing 1 - 11 results of 11
-
1
-
2
-
3
-
4
Comanagement with rheumatology and prescription biologics filled during pregnancy in women with rheumatic diseases: a retrospective analysis of US administrative claims data by Jonathan Kay, Kate L Lapane, Divya Shridharmurthy, Jonggyu Baek, Anthony Nunes, Shao-Hsien Liu
Published in BMJ Open (2022-12-01)Get full text
Article -
5
Treatment Persistence and Switching Patterns of Adalimumab Biosimilar ABP 501 in European Patients with Rheumatologic Diseases by Ran Jin, Silvia Kruppert, Florian Scholz, Isabelle Bardoulat, Khalil Karzazi, Francois Morand, Greg Kricorian, David Collier, Jonathan Kay
Published in Rheumatology and Therapy (2024-03-01)Get full text
Article -
6
Fipronil and ivermectin treatment of cattle reduced the survival and ovarian development of field-collected Anopheles albimanus in a pilot trial conducted in northern Belize by Staci M. Dreyer, Donovan Leiva, Marla Magaña, Marie Pott, Jonathan Kay, Alvaro Cruz, Nicole L. Achee, John P. Grieco, Jefferson A. Vaughan
Published in Malaria Journal (2019-08-01)Get full text
Article -
7
A new education agenda based on The International Science and Evidence Based Education Assessment by Nandini Chatterjee Singh, Tal Gilead, Anya Chakraborty, Jo Van Herwegen, Nienke van Atteveldt, Gregoire Borst, Stephanie Bugden, Kaja Jasinska, Jonathan Kay, Kenneth Pugh, Anantha Duraiappah
Published in npj Science of Learning (2025-05-01)Get full text
Article -
8
Examining Treatment Decision‐Making Among Patients With Axial Spondyloarthritis: Insights From a Conjoint Analysis Survey by Woojin Joo, Christopher V. Almario, Mariko Ishimori, Yujin Park, Alma Jusufagic, Benjamin Noah, Lianne S. Gensler, R. Swamy Venuturupalli, Jonathan Kay, Michael H. Weisman, Brennan M.R. Spiegel
Published in ACR Open Rheumatology (2020-07-01)Get full text
Article -
9
Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2 by Sofia Ramiro, Atul Deodhar, Philip J Mease, Martin Rudwaleit, Jonathan Kay, Marina Magrey, Victoria Navarro-Compán, Vanessa Taieb, Carmen Fleurinck, Ute Massow, Michael F Mørup, Christine de la Loge
Published in RMD Open (2024-05-01)Get full text
Article -
10
Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLUTION, a pragm... by Alexis Ogdie, Soumya M. Reddy, Sarah H. Gillespie, M. Elaine Husni, Jose U. Scher, Karen Salomon-Escoto, Jonathan Kay, Brent A. Luedders, Jeffrey R. Curtis, Alisa J. Stephens Shields, Soumya D. Chakravarty, Cinty Gong, Jessica A. Walsh
Published in Trials (2025-03-01)Get full text
Article -
11
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates by Claudia Buhigas, Anne Y. Warren, Wing-Kit Leung, Hayley C. Whitaker, Hayley J. Luxton, Steve Hawkins, Jonathan Kay, Adam Butler, Yaobo Xu, Dan J. Woodcock, Sue Merson, Fiona M. Frame, Atef Sahli, Federico Abascal, CRUK-ICGC Prostate Cancer Group, Iñigo Martincorena, G. Steven Bova, Christopher S. Foster, Peter Campbell, Norman J. Maitland, David E. Neal, Charlie E. Massie, Andy G. Lynch, Rosalind A. Eeles, Colin S. Cooper, David C. Wedge, Daniel S. Brewer
Published in Molecular Cancer (2022-09-01)Get full text
Article
